BPA for letairis, yescarta, and tecartus
Active Awarded Last action
- Contract number
- 36E79722A0029
- Awardee
-
Gilead Sciences Inc. UEI FPJMGUK1BYH8
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- VA797P12Q0002 Solicitation number
- Last date to order 80% complete
- IDV ceiling
- $29,160,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Veterans Affairs National Acquisition Center established a Blanket Purchase Agreement with Gilead Sciences Inc. on November 1, 2022, with a ceiling of $29.16 million and an ultimate completion date of October 31, 2027. The BPA is structured under the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule.
The BPA covers procurement of specialized pharmaceutical products including Letairis, Yescarta, Tecartus, and Livdelzi. The agreement enables VA medical facilities nationwide to order these critical medications through established BPA call procedures, supporting oncology, antiviral, and other therapeutic needs across the Veterans Integrated Service Networks.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Show all 16
Quick answers
Who was awarded contract 36E79722A0029?
36E79722A0029 was awarded to Gilead Sciences Inc. by National Acquisition Center (Headquarters) on November 1, 2022.
How much is contract 36E79722A0029 worth?
36E79722A0029's own ceiling is $29,160,000.
Who can order from contract 36E79722A0029?
36E79722A0029 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36E79722A0029 under another contract?
Yes. 36E79722A0029 is a blanket purchase agreement under V797D70252, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36E79722A0029 competed?
The extent of competition for 36E79722A0029 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV